Market closedNon-fractional
AngioDynamics/ANGO
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About AngioDynamics
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.
Ticker
ANGO
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Latham, United States
Employees
815
Website
www.angiodynamics.com
AngioDynamics Metrics
BasicAdvanced
$301M
Market cap
-
P/E ratio
-$4.59
EPS
0.66
Beta
-
Dividend rate
Price and volume
Market cap
$301M
Beta
0.66
Financial strength
Current ratio
2.12
Quick ratio
1.313
Management effectiveness
Return on assets (TTM)
-4.98%
Return on equity (TTM)
-63.15%
Valuation
Price to revenue (TTM)
0.993
Price to book
1.48
Price to tangible book (TTM)
2.37
Price to free cash flow (TTM)
-8.895
Growth
Revenue change (TTM)
-10.28%
Earnings per share change (TTM)
245.11%
3-year revenue growth (CAGR)
1.46%
3-year earnings per share growth (CAGR)
77.35%
What the Analysts think about AngioDynamics
Analyst Ratings
Majority rating from 4 analysts.
AngioDynamics Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$75M
-4.94%
Net income
-$188M
547.24%
Profit margin
-249.93%
581.01%
AngioDynamics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$0.02
-$0.12
-$0.05
-$0.16
-
Expected
$0.02
-$0.13
-$0.08
-$0.14
-$0.16
Surprise
-11.11%
-7.69%
-33.33%
18.30%
-
AngioDynamics News
AllArticlesVideos
Medical Devices Maker AngioDynamics Lays Out Growth Plans, Issues Upbeat Annual Guidance
Benzinga·1 week ago
AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System
Business Wire·2 months ago
AngioDynamics' APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for AngioDynamics stock?
AngioDynamics (ANGO) has a market cap of $301M as of July 27, 2024.
What is the P/E ratio for AngioDynamics stock?
The price to earnings (P/E) ratio for AngioDynamics (ANGO) stock is 0 as of July 27, 2024.
Does AngioDynamics stock pay dividends?
No, AngioDynamics (ANGO) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next AngioDynamics dividend payment date?
AngioDynamics (ANGO) stock does not pay dividends to its shareholders.
What is the beta indicator for AngioDynamics?
AngioDynamics (ANGO) has a beta rating of 0.66. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell AngioDynamics stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.